Retatrutide Study Examines Dosing in Non-Diabetic Obesity Participants | Retatrutide News

A study is examining the efficacy and safety of Retatrutide in non-diabetic individuals with obesity. The trial spans approximately 113 weeks and is not...
Clinical Trials · October 16, 2026